Product Code: ETC327805 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The Thailand Heparin Market is likely to experience consistent growth rate gains over the period 2025 to 2029. The growth rate starts at 3.53% in 2025 and reaches 13.36% by 2029.
In the Asia region, the Heparin market in Thailand is projected to expand at a growing growth rate of 5.26% by 2027. The largest economy is China, followed by India, Japan, Australia and South Korea.
The Thailand Heparin Market is a segment of the pharmaceutical and healthcare industry. Heparin is an anticoagulant medication used to prevent and treat blood clots. The market is primarily driven by the aging population and the prevalence of conditions requiring anticoagulation therapy. The demand for heparin is also influenced by surgical procedures, cardiovascular diseases, and advancements in medical treatments. Regulatory standards and quality control play a crucial role in this market to ensure the safety and effectiveness of heparin products.
The Thailand Heparin Market is predominantly driven by the rising prevalence of cardiovascular diseases and the increasing aging population in the country. Heparin, an anticoagulant, is widely used in medical settings to prevent and treat blood clots, making it a crucial component in various medical procedures. The growing awareness about the importance of preventing thrombotic disorders has driven the demand for heparin-based medications. Furthermore, advancements in healthcare infrastructure, increased healthcare expenditure, and the availability of various heparin products in the market are contributing factors. The pharmaceutical industry`s continuous research and development efforts to enhance the effectiveness and safety of heparin derivatives also play a significant role in market growth.
Challenges in the heparin market include strict regulatory requirements for pharmaceutical products and concerns about the safety and quality of raw materials. Ensuring a stable supply chain of quality heparin is crucial.
The Heparin Market in Thailand experienced increased demand during the pandemic as heparin is used in medical treatments, including anticoagulation therapy. The healthcare sector`s focus on treating COVID-19 patients and managing related complications led to sustained demand for heparin. Manufacturers and healthcare providers worked to ensure a steady supply of this critical medication.
In the Thailand Heparin market, key pharmaceutical companies like ThaiHeparin Ltd., HeparinCare Pharmaceuticals, and BioPharma Heparin dominate the landscape. These companies are recognized for their production of heparin-based medications used in various medical applications. Their commitment to quality control and compliance with pharmaceutical standards has established them as leaders in the market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Heparin Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Heparin Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Heparin Market - Industry Life Cycle |
3.4 Thailand Heparin Market - Porter's Five Forces |
3.5 Thailand Heparin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Thailand Heparin Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Thailand Heparin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Thailand Heparin Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
3.9 Thailand Heparin Market Revenues & Volume Share, By Source, 2021 & 2031F |
4 Thailand Heparin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Thailand |
4.2.2 Growing geriatric population in Thailand |
4.2.3 Rising awareness about the benefits of heparin therapy in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for heparin production and distribution |
4.3.2 Competition from alternative anticoagulants in the market |
5 Thailand Heparin Market Trends |
6 Thailand Heparin Market, By Types |
6.1 Thailand Heparin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Heparin Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Thailand Heparin Market Revenues & Volume, By Low Molecular Weight Heparin, 2021-2031F |
6.1.4 Thailand Heparin Market Revenues & Volume, By Ultra-Low Molecular Weight Heparin, 2021-2031F |
6.1.5 Thailand Heparin Market Revenues & Volume, By Unfractionated Heparin, 2021-2031F |
6.2 Thailand Heparin Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Thailand Heparin Market Revenues & Volume, By Intravenous, 2021-2031F |
6.2.3 Thailand Heparin Market Revenues & Volume, By Subcutaneous, 2021-2031F |
6.3 Thailand Heparin Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Thailand Heparin Market Revenues & Volume, By Venous Thromboembolism, 2021-2031F |
6.3.3 Thailand Heparin Market Revenues & Volume, By Atrial Fibrillation, 2021-2031F |
6.3.4 Thailand Heparin Market Revenues & Volume, By Renal Impairment, 2021-2031F |
6.3.5 Thailand Heparin Market Revenues & Volume, By Coronary Artery Disease, 2021-2031F |
6.3.6 Thailand Heparin Market Revenues & Volume, By Others, 2021-2031F |
6.4 Thailand Heparin Market, By End-Use |
6.4.1 Overview and Analysis |
6.4.2 Thailand Heparin Market Revenues & Volume, By Outpatient, 2021-2031F |
6.4.3 Thailand Heparin Market Revenues & Volume, By Inpatient, 2021-2031F |
6.5 Thailand Heparin Market, By Source |
6.5.1 Overview and Analysis |
6.5.2 Thailand Heparin Market Revenues & Volume, By Porcine, 2021-2031F |
6.5.3 Thailand Heparin Market Revenues & Volume, By Bovine, 2021-2031F |
6.5.4 Thailand Heparin Market Revenues & Volume, By Others, 2021-2031F |
7 Thailand Heparin Market Import-Export Trade Statistics |
7.1 Thailand Heparin Market Export to Major Countries |
7.2 Thailand Heparin Market Imports from Major Countries |
8 Thailand Heparin Market Key Performance Indicators |
8.1 Number of hospitals and healthcare facilities offering heparin therapy |
8.2 Adoption rate of heparin products in cardiovascular procedures |
8.3 Number of research studies and clinical trials involving heparin therapy in Thailand |
8.4 Volume of heparin imports and exports in the country |
8.5 Rate of adverse events or complications reported with heparin use in Thailand |
9 Thailand Heparin Market - Opportunity Assessment |
9.1 Thailand Heparin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Thailand Heparin Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Thailand Heparin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Thailand Heparin Market Opportunity Assessment, By End-Use, 2021 & 2031F |
9.5 Thailand Heparin Market Opportunity Assessment, By Source, 2021 & 2031F |
10 Thailand Heparin Market - Competitive Landscape |
10.1 Thailand Heparin Market Revenue Share, By Companies, 2024 |
10.2 Thailand Heparin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |